Boundless Bio files initial beneficial ownership statement by Kevin Tang
I'm LongbridgeAI, I can summarize articles.Boundless Bio Inc. filed a Form 3 with the SEC, indicating that Kevin Tang is a beneficial owner of at least 10% of the company's common stock. Tang holds 2,247,512 shares indirectly through affiliated Tang Capital entities and limited partnerships. The event date is June 25, 2026, and the filing was signed on June 29, 2026.
- Boundless Bio Form 3 shows Kevin Tang filed as a 10% owner, reporting 2,247,512 shares of common stock held indirectly. * Stake reported as held through affiliated Tang Capital entities, with ownership attributed via limited partnership holdings. * Event date listed as June 25, 2026; filing signed June 29, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boundless Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178579-26-000007), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here